Cepritect 250 mg Intramammary Suspension for Dry Cows
Cepritect 250 mg Intramammary Suspension for Dry Cows
Authorised
- Cefalonium dihydrate
Product identification
Medicine name:
Cepritect 250 mg Intramammary Suspension for Dry Cows
Active substance:
- Cefalonium dihydrate
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefalonium dihydrate269.63/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal21day
-
Milk96hourafter calving if the dry period is longer than 54 days
-
Milk58dayfollowing treatment if the dry period is less than or equal to 54 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DB90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Available in:
-
Italy
Package description:
- Single dose 3g white LDPE syringes with a white LDPE dual push-fit cap.Buckets of 120 syringes including 120 individually wrapped teat cleaning towels containing isopropyl alcohol.
- Single dose 3g white LDPE syringes with a white LDPE dual push-fit cap.Cartons of 60 syringes including 60 individually wrapped teat cleaning towels containing isopropyl alcohol.
- Single dose 3g white LDPE syringes with a white LDPE dual push-fit cap.Cartons of 24 syringes including 24 individually wrapped teat cleaning towels containing isopropyl alcohol.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Manufacturing Limited
- Norbrook Laboratories Limited
Responsible authority:
- Ministry Of Health
Authorisation number:
- 105086
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0559/001
Concerned member states:
-
Austria
-
Bulgaria
-
Czechia
-
Estonia
-
France
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet